Zydus Lifesciences Ltd.

NSE: ZYDUSLIFE | BSE: 532321 | ISIN: INE010B01027 | Industry: Pharmaceuticals
| Mid-range Performer
974.7000 14.55 (1.52%)
NSE Jun 09, 2025 13:43 PM
Volume: 459.3K
 

974.70
1.52%
KRChoksey
In Q3FY23, ZYDUSLIF reported strong growth across businesses. The company’s key markets i.e. India and the US, have reported double digit growth of 12.5% and 29.3% respectively. The Indian business revenue was at INR 16436mn up 13% YoY. The Indian formulation business registered revenues of INR 12316mn and contributed around 30% of consolidated revenues (excluding COVID related issues).
Zydus Lifesciences Ltd. is trading above all available SMAs
More from Zydus Lifesciences Ltd.
Recommended